For children with atopic dermatitis (AD), early childhood stressful life events are associated with an increased ris ...

US-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA ...

Healio Dermatology will be reporting live at South Beach Symposium 2025 from Feb. 6 to 8 in Miami Beach, Florida. The 23rd ...

ENV-294 is a clinical-stage small molecule designed to address the shared pathways underlying multiple inflammatory conditions via a first-in-class mechanism. ENV-294 entered Phase 1 studies in ...

A small cohort study found that a wearable hand sensor that uses artificial intelligence reduced subconscious nighttime ...

Tapinarof, however, offers a potential solution by improving the skin barrier, reducing inflammation and relieving itch ...

Diagnosing atopic dermatitis is a matter of just ruling out all other causes of itching, which can be somewhat difficult at ...

Atopic dermatitis is a chronic inflammatory skin disease affecting a growing number of people worldwide. Marked by persistent ...

Apogee Therapeutics, Inc. (NASDAQ: APGE) has announced the dosing of the first patient in the part B portion of the phase 2 ...

Comment by Feb. 17 for your feedback to be reviewed by the guideline development workgroup.

The global atopic dermatitis treatment market is on the cusp of remarkable expansion, with projections indicating a surge in ...

After doctors dismissed Rheanca's pain because they couldn't see where it hurt, she knew people with disability in regional ...